![]() |
![]() |
![]() |
|
CLDA Featured Presentation at 20th Annual Bear Stearns Healthcare Conference CEO Drew Fromkin discusses CLDA, and CMO Carol Reed, M.D. outlines positive results from Vilazodone Phase III trial. |
| Clinical Data © 1999-2008. All Rights Reserved. Terms of Use. |